Epitopes of group A streptococcal M protein that evoke cross-protective local immune responses
- PMID: 1370521
Epitopes of group A streptococcal M protein that evoke cross-protective local immune responses
Abstract
The present studies were undertaken to identify conserved epitopes of group A streptococcal M proteins that evoke cross-protective mucosal immune responses. Two synthetic peptides copying conserved regions of type 5 M protein, designated SM5(235-264)C and SM5(265-291)C, were covalently linked to carrier molecules and their immunogenicity was tested in laboratory animals. Rabbit antisera against both peptides cross-reacted with multiple serotypes of group A streptococci, indicating that the peptides contained broadly cross-reactive, surface exposed M protein epitopes. Serum antipeptide antibodies adsorbed to the surface of heterologous type 24 streptococci passively protected mice against intranasal challenge infections. Mice that were actively immunized intranasally with each synthetic peptide covalently linked to the B subunit of cholera toxin were protected against colonization and death after intranasal challenge infections with type 24 streptococci in the absence of serum opsonic antibodies. These data confirm and extend previous observations that conserved M protein epitopes evoke cross-protective local immunity and may serve as the basis for broadly cross-protective M protein vaccines.
Similar articles
-
Synthetic peptide vaccine against mucosal colonization by group A streptococci. I. Protection against a heterologous M serotype with shared C repeat region epitopes.J Immunol. 1990 Aug 15;145(4):1251-6. J Immunol. 1990. PMID: 1696296
-
Recombinant tetravalent group A streptococcal M protein vaccine.J Immunol. 1993 Aug 15;151(4):2188-94. J Immunol. 1993. PMID: 8345202
-
Epitopes of streptococcal M proteins that evoke antibodies that cross-react with human brain.J Immunol. 1993 Sep 1;151(5):2820-8. J Immunol. 1993. PMID: 7689617
-
Group A streptococcal M proteins: virulence factors and protective antigens.Immunol Today. 1992 Sep;13(9):362-7. doi: 10.1016/0167-5699(92)90173-5. Immunol Today. 1992. PMID: 1281632 Review.
-
Protective and autoimmune epitopes of streptococcal M proteins.Vaccine. 1988 Apr;6(2):192-6. doi: 10.1016/s0264-410x(88)80027-6. Vaccine. 1988. PMID: 3291457 Review.
Cited by
-
A lipid core peptide construct containing a conserved region determinant of the group A streptococcal M protein elicits heterologous opsonic antibodies.Infect Immun. 2002 May;70(5):2734-8. doi: 10.1128/IAI.70.5.2734-2738.2002. Infect Immun. 2002. PMID: 11953422 Free PMC article.
-
Immunological relationship between the class I epitope of streptococcal M protein and myosin.Infect Immun. 1998 Sep;66(9):4418-24. doi: 10.1128/IAI.66.9.4418-4424.1998. Infect Immun. 1998. PMID: 9712796 Free PMC article.
-
Advances in potential M-protein peptide-based vaccines for preventing rheumatic fever and rheumatic heart disease.Immunol Res. 2006;35(3):233-48. doi: 10.1385/IR:35:3:233. Immunol Res. 2006. PMID: 17172649 Review.
-
Cloning, sequencing, and expression of a fibronectin/fibrinogen-binding protein from group A streptococci.Infect Immun. 1994 Sep;62(9):3937-46. doi: 10.1128/iai.62.9.3937-3946.1994. Infect Immun. 1994. PMID: 8063411 Free PMC article.
-
Clearance of Pseudomonas aeruginosa from the murine gastrointestinal tract is effectively mediated by O-antigen-specific circulating antibodies.Infect Immun. 1995 Aug;63(8):2818-25. doi: 10.1128/iai.63.8.2818-2825.1995. Infect Immun. 1995. PMID: 7542632 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources